Pill Imprint Cipla 031 150 mg
This red capsule-shape pill with imprint Cipla 031 150 mg on it has been identified as: Nilotinib 150 mg.
This medicine is known as nilotinib. It is available as a prescription only medicine and is commonly used for Chronic Myelogenous Leukemia.
Details for pill imprint Cipla 031 150 mg
- Drug
- Nilotinib
- Imprint
- Cipla 031 150 mg
- Strength
- 150 mg
- Color
- Red
- Shape
- Capsule-shape
- Availability
- Prescription only
Pill Classification
- National Drug Code (NDC)
- 690970031
Read this next
-
Leukemia: Understanding the Basics
Leukemia is a type of blood cancer that interferes with the body’s ability to produce normal types of white blood cells
-
Stages of Leukemia: What You Should Know
During a diagnosis of leukemia, one of the most important determinations a doctor makes is the stage, which describes the degree and seriousness of the cancer
-
Factors That Affect Leukemia Survival Rates
The survival rate of leukemia varies markedly, depending on the age of the person with leukemia and the type of leukemia.
-
Leukemia vs. Lymphoma: What’s the Difference?
Both diseases are blood cancers, but leukemia is found in the blood and bone marrow while lymphoma appears in the lymph nodes
